Alzheimer's Club

A forum for non-censored ideas, news, research and technology on Alzheimer's disease


			_


							_

Alzheimer's cure: World General Media News Headlines

Alzheimer's treatment: World General Media News Headlines

Alzheimer theories: World General Media News Headlines

Alzheimer science professional news: Alzforum News & Views

November 13, 2004

Lay news: Wall Street Journal Covers Alzheimer's Research

Sharon Begley, Science Journal: Is Alzheimer's Field Blocking Research Into Other Causes?" (9 April 2004, WSJ p.B.1) [Free FullText at SFChronicle]

Sharon Begley, "Science Journal: Scientists World-Wide Battle a Narrow View Of Alzheimer's Cause" (16 April 2004, The Wall Street Journal, WSJ p.A.9) [Free FullText at SFChronicle]

Robert Mahley, Sheldon Goldberg, Richard Sheldon, "Letter to the editor: Does Bias Confound Alzheimer's Research?" (27 April 2004, WSJ, p.A.19 [FullText at UCDavis ADRC] [Alexei Koudinov letter to WSJ]

1 Comments:

At 11/16/2005 5:29 PM, Vijaya B. Kumar said…

The amyloid beta ptoein may not be the only monster, or even may not be the monster at all. My reasearch showed that reducing the amyloid precursor protein expression using antisense did improve the memory in mice considerably. If amyloid peptide has no role to play in AD, how would we explain the famous mutations in APP that enhance the accumulation of betaprotein also cause AD?. I think, formation of insoluble plaques may be the way in which the brain fights a soluble toxic agent or it indirectly generates. It is almost impossible to get a few dollars for alternate studies any way. I have lipid theory and complement theory, both were shot in their heart, dispite reasonable evidence I presented. If some one who sees this letter gives me a lead to which agency I may approach for few dollars to conduct AD research that involves other theories, I would be obliged. Vijaya B. Kumar, Ph.D.

Latest PubMed 20 review articles on Alzheimer’s

Latest PubMed 20 research articles on Alzheimer’s amyloid

Latest PubMed 50 research titles on Alzheimer’s

AlzClub Lay and Science News content is under automatic continuous update. Please check back often or subscribe to news of interest using RSS feed buttons below. Also, please email to us your news terms suggestions
A semi-fiction mystery novel "The Alzheimer Code" is under preparation. In this book the death of the President of the United States of America is followed by his preventive anti-amyloid vaccination against Alzheimer's disease. At the same time and for the same reason, in his agony of death Editor-in-Chief of London-based Nature science journal recalls he in fact witnessed the corruption of Alzheimer's pseudo-science, brought to the community by a keen student. This is a story of a corrupted Harvard University professor, a research center co-director and a godfather of the international network of science criminals. Be the first to know when Alzheimer Code is published, by subscribing to an AlzClub.org news alerts . Otherwise automate your Alzheimer’s information portfolio with a number of options presented at this page.
Subscribe to AlzClub Mailing List, and freely share your information directly with your peers by e-mail. Click here to prepare email message requesting AlzClub Mailing List subscription
Would you like to author articles at Alzheimer's Club? Then send us your masterpiece, so we can screen it and publish at Alzclub.org. Please note that comments (on articles published previously) can be posted directly and anonymously (but why you would stay not known to the public?)
Do you know that as of May 3, 2005 NIH asks NIH-funded scientists to deposit their articles (published earlier in scientific journals) in PubMedCentral (PMC)? PMC is accessible to all for free and is one form of the academic world movement towards Public Open Access to scholar literature, free from commercial publishers' cabal. New to Open Access? Then you miss important science publishing development, because an NIH provision became a US law at the end of 2007. Read lay language article on Open Access authored by AlzClub founder. NIH-funded authors: visit the NIH Manuscript Submission system for more information.